Renal
fibrosis and
inflammation are common underlying processes of progressive
kidney diseases. Elongator
protein 2 (Elp2), identical to signal transducer and activator of transcription-3 (STAT-3)-interacting protein-1 (Stip1), is a component of the Elongator complex that regulates
RNA polymerase II. Elp2 regulates STAT-3 activation to control various cellular processes. The mechanisms of Elp2 prevention in renal interstitial
fibrosis and
inflammation remain unknown. In the study, Elp2 transgenic knockout (KO) and wild type (WT) mice were employed to investigate the effects of Elp2 on renal
fibrosis and
inflammation development after unilateral ureter obstruction (UUO) surgery. The results indicted that Elp2 was significantly expressed in renal tissues of WT/UUO mice. Elp2-KO mice exhibited attenuated histological changes of kidney, as well as
collagen and
fibrosis accumulation. Lower expressions of
transforming growth factor (TGF)-β1, α-smooth muscle actin (α-SMA),
fibronectin,
vimentin, and phospho-Smad2/3 were observed in kidney of Elp2-KO mice than that of WT mice after UUO. Elp2-KO mice showed less
inflammation, as evidenced by the decrease of circulating or renal pro-inflammatory
cytokines, as well as the reduction of phospho-nuclear factor (NF)-κB. Additionally, Elp2-KO apparently led to a decrease in phospho-STAT3 in kidney of UUO mice. In vitro, we found that TGF-β1- and LPS-induced
fibrosis and
inflammation were abrogated by Elp2 knockdown, which were intriguingly abolished by activating STAT3 phosphorylation using its activator of
colivelin (Col). Together, our findings supplied that Elp2 might be a potential therapeutic target to prevent the progression of renal
fibrosis and
inflammation.